Tumor Immunotherapy
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
Cancer Therapies
Cancer
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 9, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Simone Hager1, Frederic Julien Fittler2, Ernst Wagner1
1Department of Chemistry and Pharmacy, Ludwig-Maximilians-University (LMU), 81377 Munich, Germany.
Nucleic acid-based drugs, including mRNA vaccines and RNA interference, are advancing cancer treatment by enhancing anti-tumor immune responses. Combination therapies with these agents and checkpoint inhibitors offer a promising strategy against tumor immune evasion.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: